• Exchange: Athens
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

LAVI:GA

0.1390 EUR 0.0120 9.45%

As of 10:10:32 ET on 04/17/2014.

Snapshot for Lavipharm SA (LAVI)

Open: 0.1390 Day's Range: 0.1390 - 0.1390 Volume: 2,500
Previous Close: 0.1270 52wk Range: 0.1010 - 0.1880 1-Yr Rtn: -21.47%

Stock Chart for LAVI

No chart data available.
  • LAVI:GA 0.1390
  • 1D
  • 1M
  • 1Y
0.1270
Interactive LAVI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LAVI

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. FTASE -
Earnings Per Share (ttm) -0.2558
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 7.10
Shares Outstanding (M) 51.08
30 Day Average Volume 5,158
Price/Book (mrq) 1.5705
Price/Sale (ttm) 0.2361
Dividend Indicated Gross Yield -%
Cash Dividend (EUR) -
Dividend Ex-Date 06/05/2009
5 Year Dividend Growth -
Next Earnings Announcement 05/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LAVI

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for LAVI

Lavipharm S.A. develops, produces, promotes, trades, and distributes cosmetics and pharmaceuticals. The Company also represents overseas drug and cosmetics companies including Avon, Hoffman La Roche, Schering Plough, 3M, and Murdipharma.

Athanase LavidasChairman/CEOTania-Panagiota VranopoulouDeputy CEO
Telemaque Jean LavidasChief Commercial OfficerSpyridon FotinosChief Scientific Officer
More Company Profile & Key Executives for LAVI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil